This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
30 Jun 2020

Catalent expands beauty and plant-based consumer health softgel capabilities

Two company sites - one in Canada, the other in Brazil - receive new softgel encapsulation lines to service local customer demand.

Catalent has completed a $3.2 million expansion program at its consumer health manufacturing facilities in Strathroy, Canada and Sorocaba, Brazil.

The expansion projects include new softgel encapsulation lines at each site, dedicated to Catalent’s proprietary Vegicaps plant-based capsule and CosmoPod twist-off capsule technologies.

The increased capacity will enable the company to support its customers in both North and Latin America to develop products for consumers seeking all-natural and plant-based vitamins, minerals and supplements, using its Vegicaps capsule; and those looking for innovative, easy-to-use, unit-dose beauty care products, through its CosmoPod technology.

“We have seen increased consumer demand for greater product choice, with sales of plant-based softgel technologies growing by more than 25% globally in recent years. Additionally, Brazil has grown to become the world’s fourth-largest market for beauty care products,” commented Dr Aris Gennadios, President, Softgel & Oral Technologies, Catalent.

Previously, Catalent's manufacturing sites in Italy and Germany supplied North and Latin Americal markets with plant-based softgel capsules.

Catalent’s 110,000-sq. ft facility in Strathroy, Ontario, and its 124,600-sq. ft facility in Sorocaba, Brazil, both offer a broad range of integrated formulation, manufacturing, and packaging services to provide full-service turnkey solutions for the pharmaceutical, consumer health, and beauty industries.

Mentioned Companies
Catalent Pharma Solutions
View company profile

Related News